International Niemann–Pick Disease Alliance
Great news for the NP-C community – the first European trial site for VTS-270 (2-hydroxypropyl-β-cyclodextrin) for Niemann-Pick Type C1 is now recruiting! Professor Marquardt of the Universitätsklinikum in Münster is the investigator contact for this location:
Thorsten Marquardt, Univ. Prof. Dr.
For more information please visit clinicaltrials.gov or the trial website developed by Vtesse at www.thenpcstudy.com. We’re delighted that a European site has started to recruit – in addition to the 4 sites already activated in the USA – and look forward to further announcements soon.